https://biotechreporter.news/united-health-pr...scussions/
In addition to its agreement with this clinical study arrangement, the FDA has approved the external audit firm that will conduct a Good Clinical Practices (GCP) audit of UHP’s protocols, procedures and personnel, as recommended by the FDA. The goal of this audit, which will be conducted in the coming months, is to assess and confirm the company’s ability to conduct its own clinical trial in accordance with all applicable FDA regulations.
There it is proof that the FDA has approved the audit firm (CPA) to conduct the audit of basically the company internal controls over procedures
including personnel! This is a defining for the company to engage with the possibility of a merger or acquisition by a pharmaceutical subsequent to
the results of the study! Up we go!
$5-$10